中信建投指出，去年下半年至今，医疗板块大幅调整，主要医疗合规要求提升和多项医改政策复合影响的背景下，预计上市公司经营存在不确定性等因素有关。受去年下半年医疗合规性要求提升影响，去年下半年和今年上半年不少器械公司业绩增速放缓，由此导致板块有所调整。从目前时点看，企业逐步适应新常态，电生理、骨科、人工晶体等多个领域高值耗材带量采购的影响逐步出清，相关龙头公司的业绩确定性和估值有望逐步修复。Orthopedic consumables concept stocks collectively declined. As of press release, Chunli Healthcare (01858) fell 5.35% to HK$6.72; Elken Healthcare (01789) fell 4.7% to HK$3.65; and Minimally Invasive Healthcare (00853) fell 2.34% to HK$4.59.
Zhitong Finance App learned that orthopedic consumables concept stocks have collectively declined. As of press release, Chunli Healthcare (01858) fell 5.35% to HK$6.72; Elken Healthcare (01789) fell 4.7% to HK$3.65; and Minimally Invasive Healthcare (00853) fell 2.34% to HK$4.59.
Zhongtai Securities pointed out that the high-value consumables sector is markedly divided, and booming racetracks such as electrophysiology continue to have a high growth trend, yet collection tracks such as orthopedics are still digesting the risk of price reduction in harvesting. The bank pointed out that under the “exhaustive harvesting” trend, most high-value consumables have now been included in the scope of national or local collection, price reduction pressure continues to be released, and the share of domestic bids for related varieties has increased significantly. It is expected to maintain rapid growth in the future. It is recommended to focus on orthopedic leaders that are about to be collected, and at the same time be optimistic about continued import substitution in the field of electrophysiology.
CITIC Construction Investment pointed out that since the second half of last year, in the context of drastic adjustments in the medical sector, the rise in major medical compliance requirements, and the combined effects of multiple health care reform policies, it is expected that there are factors such as uncertainty about the operations of listed companies. Affected by the increase in medical compliance requirements in the second half of last year, the performance growth rate of many device companies slowed in the second half of last year and the first half of this year, leading to sector adjustments. Judging from the current point of view, enterprises are gradually adapting to the new normal, the impact of volume procurement of high-value consumables in various fields such as electrophysiology, orthopedics, and intraocular lenses is gradually being clarified, and the performance certainty and valuation of relevant leading companies is expected to gradually recover.